Agilon raises 2026 outlook to $5.88B revenue and $150M adjusted EBITDA while expecting 40%-50% ACO membership growth in 2027 (NYSE:AGL)
· seekingalpha.com
agilon health raised 2026 guidance after a strong Q3, with improving margins, MSER, and ACO growth.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...